<DOC>
	<DOC>NCT01110512</DOC>
	<brief_summary>It is hoped that with the use of medication, occurs improvement of the CVI parameters, such as edema, pain, night cramps, functional discomfort, heavy feeling and that the drug test is non-inferior than the comparator.</brief_summary>
	<brief_title>Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI)</brief_title>
	<detailed_description />
	<mesh_term>Venous Insufficiency</mesh_term>
	<criteria>Subjects who agree to the terms described in IC; Subjects of both genders, aged ≥ 18 and ≤ 75 years with IVC framework of the lower limbs; Subjects with CVI ranked 3 to 5, according to CEAP scale; Patients complaining of pain and swelling in the lower limbs secondary to IVC; Subjects with good mental health that can respond adequately to the study questionnaires; Subjects who agree to make any return visits for evaluation; Patients with CVI classified as 0, 1, 2 or 6, according to CEAP; Subjects who have received treatment for varicose veins as laser, medication use topical or oral (eg: brown India, coumarin, and etc.). And surgery in the 03 months preceding the study; Patients with other diseases that may interfere with the study results: thrombosis, coagulation disorders and other diseases that the medical criteria, are important to be excluded; Pregnant or nursing women; Presence of any medical condition that, according to the investigator, should prevent the patient from the study; Participation in clinical trials in the twelve months preceding the study; Patients with serious illnesses and uncontrolled that need multidrug treatment; Patients on diuretics of any kind, regardless of pathology (hypertension, renal or liver disease); Values of laboratory tests appropriate security; the Hemoglobin &lt;10 mg / mL the creatinine&gt; 1.5 mg / mL; AST, ALT, GGT ≥ 2 times normal values; the platelet count below 90.000/ml; Total Bilirubin and the fractions ≤ 1.5 times the normal range. past medical history of hypersensitivity to drugs of the same pharmacological classes of substances under investigation;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Improvement of CVI parameters</keyword>
</DOC>